Elevated concentrations of soluble adhesion molecules and large platelets in diabetic patients: Are they markers of vascular disease and diabetic nephropathy?

Clinical and Applied Thrombosis/Hemostasis

Volumn 13, Issue 4, 2007, Pages 391-397

  Bavbek, N ^a,b   Kargili, A ^a   Kaftan, O ^a   Karakurt, F ^a   Kosar, A ^a   Akcay, A ^a  

^a FATIH UNIVERSITY MEDICAL SCHOOL   (Turkey)

^b NONE   (Turkey)

Author keywords

Complications; Diabetes mellitus; E selectin; Mean platelet volume; P selectin

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HEMOGLOBIN; PADGEM PROTEIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; FEMALE; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HUMAN; ISCHEMIC HEART DISEASE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; THROMBOCYTE VOLUME; VASCULAR DISEASE; AGED; BLOOD; CASE CONTROL STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIABETIC ANGIOPATHY; DIABETIC RETINOPATHY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; SOLUBILITY; THROMBOCYTE;

AGED; BIOLOGICAL MARKERS; BLOOD PLATELETS; CASE-CONTROL STUDIES; CORONARY ARTERIOSCLEROSIS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; E-SELECTIN; FEMALE; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PROTEINURIA; SOLUBILITY;

EID: 35748946044     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029607303615     Document Type: Article

References (50)

1. Colwell JA Vascular thrombosis in type II diabetes mellitus. Diabetes. 1993 ; 42: 8-11.
2. Ruggenenti P., Remuzzi G. The diagnosis of renal involvement in non-insulin-dependent diabetes mellitus. Curr Opin Nephrol Hypertens. 1997 ; 6: 141-145.
3. UK Prospective Diabetes Study. IX. Relationships of urinary albumin and N-acetylglucosaminidase to glycaemia and hypertension at diagnosis of type 2 diabetes mellitus and after 3 months' diet therapy. Diabetologia. 1993 ; 36: 835-842.
4. Ritz E., Orth SR Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med. 1999 ; 341: 1127-1133.
5. Tschoepe D., Roesen P., Eser J., et al. Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost. 1991 ; 17: 433-438.
6. Tschoepe D., Driesch E., Schwippert B., et al. Exposure of adhesion molecules on activated platelets in patients with newly diagnosed IDDM is not normalized by nearnormoglycemia. Diabetes. 1995 ; 44: 890-894.
7. Colwell JA, Winocour PD, Halushka PV, et al. Do platelets have anything to do with diabetic microvascular disease? Diabetes. 1983 ; 32: 14-19.
8. Vukovich TC, Schernthaner G., Knobi PN, et al. The effect of near-normoglycemic control on plasma factor VIII/von Willebrand factor and fibrin degradation products in insulin-dependent diabetic patients. J Clin Endocrinol Metab. 1989 ; 69: 84-89.
9. Fasching P., Veilt M., Rohac M., et al. Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1996 ; 8: 4313-4317.
10. Jude EB, Abbott CA, Andersen S., et al. The potential role of cell adhesion molecules in the pathogenesis of diabetic neuropathy. Diabetologia. 1998 ; 41: 330-336.
11. Gearing Ajh, Hemingway I., Pigott R., et al. Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathologic significance. Ann NY Acad Sci. 1992 ; 667: 324-331.
12. Fasching P., Waldhausl W., Wagner OF Elevated circulating adhesion molecules in NIDDM-potential mediators in diabetic microangiopathy. Diabetologia. 1996 ; 39: 1242-1244.
13. Schmidt AM, Crandall J., Hori O., et al. Elevated plasma levels of vascular cell adhesion molecule-1 in diabetic patients with microalbuminuria: a marker of vascular dysfunction and progressive vascular disease. Br J Haematol. 1996 ; 92: 747-750.
14. Steiner M., Reinhardt KM, Krammer B., et al. Increased levels of soluble adhesion molecules are independent of glycaemic control. Thromb Haemost. 1994 ; 72: 979-984.
15. Cominacini L., Pasini AF, Garbin U., et al. Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control. Diabetologia. 1995 ; 38: 1122-1124.
16. Lampeter ER, Kishimoto TK, Rothlein R., et al. Elevated levels of circulating adhesion molecules in IDDM and in subjects at risk for IDDM. Diabetes. 1992 ; 4: 1668-1672.
17. Aliberti G., D'Erasmo E., Vecci E., et al. Platelet parameters in aged non insulin dependent diabetics. Arch Gerontol Geriatr. 1991 ; 12: 255-258.
18. Erikson U., Ewald U., Tuvemo T. Increased platelet volume in manifest diabetic rats. Ups J Med Sci. 1983 ; 88: 17-23.
19. Rao AK, Goldberg RE, Walsh PN Platelet coagulant activities in diabetes mellitus. Evidence for relationship between platelet coagulant hyperactivity and platelet volume. J Lab Clin Med. 1984 ; 103: 82-92.
20. Cagliero E., Porta M., Cousins S., et al. Increased platelet volume in diabetic retinopathy. Haemostasis. 1982 ; 12: 293-299.
21. Tschoepe D., Roesen P., Eser J., et al. Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Haemost. 1991 ; 17: 433-438.
22. Porta M., Peters AM, Cousins SA, et al. A study of platelet-relevant parameters in patients with diabetic microangiopathy. Diabetologia. 1983 ; 25: 21-25.
23. Bennett PH The diagnosis of diabetes: new international classification and diagnostic criteria. Annu Rev Med. 1983 ; 34: 295-309.
24. Kroc Collaborative Study Group. Blood glucose control and the evolution of diabetic retinopathy and albuminuria: a preliminary multicenter trial. N Engl J Med. 1984 ; 311: 365-372.
25. Lauritzen T., Frost-Larsen K., Larsen H-W., et al. Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes. 1985 ; 34: 74-79.
26. Zhao Y., He Y., Shen W., et al. Plasma P-selectin measurement using immunoassay method and its clinical significance. J Exp Haematol. 1997 ; 5: 426-428.
27. Ruderman NB, Grupta S., Susman I. Hyperglycemia, diabetes and vascular disease: an overview. In: Ruderman NB, Williamson J., Brownless M., eds. Hyperglycemia, Diabetes and Vascular Disease. New York: Oxford University Press; 1992: 3-20.
28. Nathan DM Long-term complications of diabetes mellitus. N Engl J Med. 1993 ; 328: 1676-1685.
29. Haffner SM, Lehto S., Ronnemaa T., et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998 ; 339: 229-234.
30. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001 ; 414: 813-820.
31. Fuller JH, Shipley MJ, Rose G., et al. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: The Whitehall Study. BMJ. 1983 ; 287: 867-870.
32. Strano A., Davi G., Patrono C. In vivo platelet activation in diabetes mellitus. Semin Thromb Haemost. 1991 ; 17: 422-430.
33. Carter AM, Grant PJ Vascular homeostasis, adhesion molecules, and macrovascular disease in non-insulin dependent diabetes mellitus. Diabet Med. 1997 ; 14: 423-432.
34. Blann AD, Lip Gyh. Endothelial integrity, soluble adhesion molecules and platelet markers in type 1 diabetes mellitus. Diabet Med. 1998 ; 15: 634-642.
35. Gearing Ajh, Newman W. Circulating adhesion molecules in disease. Immunol Today. 1993 ; 14: 506-512.
36. Jude EB, Abbott CA, Young MJ, et al. The potential role of cell adhesion molecules in the pathogenesis of diabetic neuropathy. Diabetologia. 1998 ; 41: 330-336.
37. McLeod DS, Lefer DJ, Merges C., et al. Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am J Pathol. 1995 ; 147: 642-665.
38. Hirata K., Shikata K., Matsuda M., et al. Increased expression of selectins in kidneys of patients with diabetic nephropathy. Diabetologia. 1998 ; 41: 185-192.
39. Martin JF, Trowbridge EA, Salmon G., et al. The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res. 1983 ; 32: 443-460.
40. Martin JF, Bath Pmw, Burr ML Influence of platelet size on outcome after myocardial infarction. Lancet. 1991 ; 338: 1409-1411.
41. D'Erasmo E., Aliberti G., Celi FS, et al. Platelet count, mean platelet volume and their relation to prognosis in cerebral infarction. J Intern Med. 1990 ; 227: 11-14.
42. Halushka PV, Lurie D., Colwell JA Increased synthesis of prostaglandin-E-like material by platelets from patients with diabetes mellitus. N Engl J Med. 1977 ; 297: 1306-1310.
43. Heath H., Bridgen WD, Canecer JV, et al. Platelet adhesiveness and aggregation in relation to diabetic retinopathy. Diabetologia. 1971 ; 7: 308-315.
44. Vicari AM, Macagni A. Primary platelet activation in recent onset type 1 diabetes mellitus. Scand J Clin Lab Invest. 1990 ; 50: 429-432.
45. Martny CN, Matthews DM, Popp-Snijders C., et al. Effects of sorbinil treatment on erythrocytes and platelets of persons with diabetes. Diabetes Care. 1986 ; 9: 36-39.
46. Sharpe PC, Trinick T. Mean platelet volume in diabetes mellitus. Q J Med. 1993 ; 86: 739-742.
47. Steiner M., Reinhardt KM, Krammer B., et al. Increased levels of soluble adhesion molecules are independent of glycaemic control. Thromb Haemost. 1994 ; 72: 979-984.
48. Cominacini L., Pasini AF, Garbin U., et al. Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control. Diabetologia. 1995 ; 38: 1122-1124.
49. Nomura S., Kagawa H., Ozaki Y., et al. Relationship between platelet activation and cytokines in systemic inflammatory response syndrome patients with hematological malignancies. Thromb Res. 1999 ; 95: 205-213.
50. Rozanski A., Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 1999 ; 99: 2192-2217.